Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |